Dermatology
News
Cases of potentially deadly fungus jump 200%: CDC
People in hospitals and nursing homes are at a heightened risk because they might have weakened immune systems or be using invasive medical...
News
Phase 3 prurigo nodularis trial shows positive results for nemolizumab
“The use of topical steroids was not allowed in this trial,” Dr. Shawn G. Kwatra said.
News
Novel therapy shows promise for treating skin-predominant dermatomyositis
The study drug “is a potent, selective humanized IgG1-neutralizing antibody directed at IFN-beta,” said Dr. Aaron Mangold, the principal...
News
Studies validate IL-17 as hidradenitis suppurativa drug target
This clearly validates this target for the control of HS," reported lead investigator Alexa B. Kimball, MD, MPH.
News
Melanoma screening: Consensus statement offers greater clarity
Overall, the panelists agreed that a risk-stratified approach is likely the most appropriate strategy for melanoma screening and follow-up and...
News
Novel single-use patch shows promise for primary axillary hyperhidrosis
“This is a new kind of device that is going to be a nice tool to have.”
News
CSU in children: Study identifies biomarkers associated with responses to different treatments
“Our study furthers our current understanding of the role of different biomarkers in treatment response.”
News
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
The recently approved deucravacitinib is the only JAK inhibitor that has so far been exempt from these warnings.
Conference Coverage
Lanolin gets nod for Allergen of the Year
Controversy continues over lanolin allergenicity; some patients with positive patch tests can tolerate lanolin ingredients.
News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....